Bengaluru (Karnataka) [India], September 8: Smytten, India’s largest tech-enabled product discovery and trial platform, has launched Smytten Pulse, a groundbreaking data solutions & consumer research platform. Smytten Pulse leverages AI and machine learning empowered with the extensive d
An increasing amount of data suggests that psychedelic substances could be beneficial in the treatment of a variety of mental health issues. However, establishing their clinical benefits and overcoming the various regulatory barriers to their usage remain significant hurdles. The September
The new device, the size and shape of a grain of rice, can run dozens of trials at once to evaluate the impact of novel medicines on some of the most difficult-to-treat brain malignancies.
Geneva [Switzerland], September 6: The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which i
The Pakistan Tehreek-e-Insaf (PTI) has expressed disappointment over the tricks that are being played to delay the hearing of the cypher case of its Chief Imran Khan and alleged that it was an attempt to deprive him of the right to a fair trial and perpetuate his detention in Attock jail.
According to the findings of a multicenter phase II clinical trial, treating patients with differentiated thyroid cancer (DTC), an advanced form of thyroid cancer that arises from thyroid follicular cells, in addition to their treatment with the targeted tyrosine kinase inhibitor (TKI) cedir
According to the findings of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Centre, adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) cediranib did not improve outcomes in patients with differ
After the PSLV-C57.1 rocket carrying the Aditya-L1 orbiter lifted off successfully from the Satish Dhawan Space Centre in Sriharikota, Andhra Pradesh on Saturday, Union Minister of State Jitendra Singh said that next will be the first trial for Gaganyaan which might happen in October.
Breast cancer is the most common disease in the European Union, accounting for 13.3 per cent of all new cancer cases in 2020. Breast cancer is expected to affect 1 in every 11 women in the EU by the age of 74.
"It's a sunshine moment for India. And secondly, like Chandrayaan, here also the whole of the nation was involved. And that's been possible because Prime Minister Modi has thrown open the gates of Sriharikota. He's brought all these stakeholders together, made them realize that this mission
Researchers have proven the efficacy of vaccines they created to prevent the disfiguring skin illness leishmaniasis in animal experiments, and the most promising candidate is currently undergoing preparation for a Phase 1 human trial.
MP Metro Corporation Director Shobhit Tandon told ANI, “On August 23, three coaches had left from Gujarat and all these coaches reached here on Wednesday night. We have unloaded one coach today, after that the remaining two coaches will be unloaded.”